Armata Pharmaceuticals ARMP 深 沪
等待开盘 07-03 09:30:00 美东时间
5.915
+0.035
+0.60%
华盛通- 最 高6.23
- 今 开5.92
- 成交量 4.17万股
- 最 低 5.72
- 昨 收 5.88
- 总市值 21.71万
- 52周最高 16.34
- 市盈率 静 --
- 换手率 0.11%
- 52周最低 2.14
- 委 比 34.55%
- 总股本 3.67万
- 历史最高 16.34
- 量 比 0.20
- 振 幅 8.67%
- 历史最低 0.8311
- 每 手 1
- 风险率 3.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Armata Pharma Receives Additional $2.5M Of Non-Dilutive DoD Funding Via Medical Technology Enterprise Consortium, Managed By Naval Medical Research Command
Supports Phase 3 readiness of AP-SA02 Non-dilutive DoD funding totals $28.7M to date LOS ANGELES, June 23, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, patho...
06-23 19:12
Armata Secures New Loan Amid Wider Quarterly Loss
Armata Pharmaceuticals ( ($ARMP) ) has provided an update. On May 13, 2026, Arm...
05-14 06:17
Armata Pharmaceuticals Q1 EPS $(3.16) Misses $(0.38) Estimate, Sales $789.000K Up From $491.000K YoY
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(3.16) per share which missed the analyst consensus estimate of $(0.38) by 731.58 percent. This is a 1480 percent decrease over losses of $(0.20) per share
05-14 04:42
Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02
Enables more frequent FDA engagement, rolling Biologic License Application review, and the potential for Accelerated Approval and Priority Review upon successful clinical development Advance...
05-07 19:00
Armata Pharmaceutics Announces Publication Of Paper In 'Communications Biology,' A Peer-Reviewed Journal From Nature Portfolio
The publication, titled, "Structural atlas of Pakpunavirus P7-1 reveals determinants of virion stability and genome ejection," describes the structure of phage P7-1, which is included in Armata's multi-phage cocktail,
05-04 19:07
Armata Pharmaceuticals Announces Structural Biology Publication in "Communications Biology"
Describes structure of phage P7-1, included in Armata's Pseudomonas aeruginosa phage cocktail, AP-PA02 LOS ANGELES, May 4, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: A...
05-04 19:00
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Intellia Therapeutics (NASDAQ:NTLA) stock rose 19.1% to $16.23 during ...
04-25 05:05
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of public offerings. Other stocks also lower.
03-27 20:10
Armata Pharmaceuticals Q4 EPS $(3.43) Misses $(0.28) Estimate, Sales $1.085M Beat $750.000K Estimate
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(3.43) per share which missed the analyst consensus estimate of $(0.28) by 1125 percent. This is a 1391.3 percent decrease over losses of $(0.23) per share
03-26 04:29
3 things to look forward to on Monday
U.S. stocks closed lower on Friday and ended lower for a fourth consecutive week as oil sustained higher prices despite efforts to minimize the impact of the war on the commodity sector. The benchmark...
03-21 04:57
